荜铃胃痛颗粒在非甾体抗炎药所致的小肠黏膜损伤中的保护作用

韩涛涛, 李可敏, 靳蕊, 等. 荜铃胃痛颗粒在非甾体抗炎药所致的小肠黏膜损伤中的保护作用[J]. 中国中西医结合消化杂志, 2023, 31(12): 934-939. doi: 10.3969/j.issn.1671-038X.2023.12.05
引用本文: 韩涛涛, 李可敏, 靳蕊, 等. 荜铃胃痛颗粒在非甾体抗炎药所致的小肠黏膜损伤中的保护作用[J]. 中国中西医结合消化杂志, 2023, 31(12): 934-939. doi: 10.3969/j.issn.1671-038X.2023.12.05
HAN Taotao, LI Kemin, JIN Rui, et al. The protective effect of Biling Weitong Granules on NSAIDs-induced small intestine injury[J]. Chin J Integr Tradit West Med Dig, 2023, 31(12): 934-939. doi: 10.3969/j.issn.1671-038X.2023.12.05
Citation: HAN Taotao, LI Kemin, JIN Rui, et al. The protective effect of Biling Weitong Granules on NSAIDs-induced small intestine injury[J]. Chin J Integr Tradit West Med Dig, 2023, 31(12): 934-939. doi: 10.3969/j.issn.1671-038X.2023.12.05

荜铃胃痛颗粒在非甾体抗炎药所致的小肠黏膜损伤中的保护作用

  • 基金项目:
    中国医学科学院医学与健康科技创新工程项目(No:2020-I2M-2-013);中国医学科学院临床与转化医学研究专项项目(No:2021-I2M-C&T-A-001)
详细信息
    通讯作者: 李景南,E-mail:lijn@pumch.cn
  • 中图分类号: R574.5; R914

The protective effect of Biling Weitong Granules on NSAIDs-induced small intestine injury

More Information
  • 目的 研究荜铃胃痛颗粒在非甾体类抗炎药(nonsteroidal anti-inflammatory drugs,NSAIDs)相关小鼠小肠损伤中的作用及对小肠真菌组成及结构的影响。方法 将15只C57/BL6雄性小鼠随机分为对照组、模型组及荜铃胃痛颗粒干预组,每组各5只,采用10 mg/kg吲哚美辛诱导小鼠小肠黏膜损伤。对照组和模型组小鼠均予0.5%羧甲基纤维素钠灌胃,荜铃胃痛颗粒干预组予灌胃荜铃胃痛颗粒,连续3 d。第3天时,模型组和荜铃胃痛颗粒干预组采用吲哚美辛灌胃制备NSAIDs相关小鼠小肠损伤模型。取小鼠小肠组织,大体观察并进行苏木精-伊红染色,采用Reuter评分及Chiu氏6级评分方法进行小肠炎症损伤程度评分。采用18S rDNA测序技术检测各组小鼠小肠真菌组成及结构改变。结果 吲哚美辛诱导小鼠小肠黏膜明显损伤,Reuter评分及组织学评分升高(P<0.05),肠道真菌α多样性和β多样性下降,而给予荜铃胃痛颗粒干预后小鼠黏膜损伤有所恢复,Reuter评分及组织学评分下降,真菌α多样性和β多样性升高(P<0.05)。FunGuide功能分析显示模型组中动物病原菌、未定义腐生真菌及木质腐生真菌等比例明显减少,而荜铃胃痛颗粒干预后上述功能菌属有所恢复。结论 荜铃胃痛颗粒能够缓解NSAIDs相关的小鼠小肠损伤,并影响肠道真菌组成及结构。
  • 加载中
  • 图 1  荜铃胃痛颗粒灌胃对NSAIDs诱导的小鼠小肠黏膜损伤的影响

    图 2  各组小鼠真菌组成结构分析

    图 3  真菌功能及相互作用预测

  • [1]

    Laine L. Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient[J]. Gastroenterology, 2001, 120(3): 594-606. doi: 10.1053/gast.2001.21907

    [2]

    施文, 王永铭, 李端, 等. 非甾体类抗炎药不良反应43年间的国内文献源分析[J]., 复旦学报(医学版), 2004, 31(5): 527-531. https://www.cnki.com.cn/Article/CJFDTOTAL-SHYK200405024.htm

    [3]

    袁耀宗. 消化性溃疡诊断与治疗规范(2016年, 西安)[J]. 中华消化杂志, 2016, 36(8): 508-513. doi: 10.3760/cma.j.issn.0254-1432.2016.08.003

    [4]

    Ishihara M, Ohmiya N, Nakamura M, et al. Risk factors of symptomatic NSAID-induced small intestinal injury and diaphragm disease[J]. Aliment Pharmacol Ther, 2014, 40(5): 538-547. doi: 10.1111/apt.12858

    [5]

    卢小芳, 张声生. 中医药治疗功能性消化不良研究进展[J]. 中国中西医结合消化杂志, 2023, 31(6): 405-410. doi: 10.3969/j.issn.1671-038X.2023.06.02

    [6]

    樊继法, 曾海松, 刘吉华. 荜铃胃痛颗粒抗实验性胃溃疡作用研究[J]. 现代药物与临床, 2022, 45(2): 259-265. https://www.cnki.com.cn/Article/CJFDTOTAL-YWPJ202202008.htm

    [7]

    苏卫仙, 刘倩, 杜丙杰, 等. 荜铃胃痛颗粒联合艾司奥美拉唑四联疗法治疗Hp相关性慢性胃炎的疗效及对外周血T淋巴细胞亚群和血清炎症相关细胞因子水平的影响[J]. 中国中西医结合消化杂志, 2022, 30(6): 419-423. doi: 10.3969/j.issn.1671-038X.2022.06.07

    [8]

    Li K, Cheng X, Jin R, et al. The influence of different proton pump inhibitors and potassium-competitive acid blockers on indomethacin-induced small intestinal injury[J]. J Gastroenterol Hepatol, 2022, 37(10): 1935-1945. doi: 10.1111/jgh.15973

    [9]

    Watanabe T, Fujiwara Y, Chan F. Current knowledge on non-steroidal anti-inflammatory drug-induced small-bowel damage: a comprehensive review[J]. J Gastroenterol, 2020, 55(5): 481-495. doi: 10.1007/s00535-019-01657-8

    [10]

    Findley K, Oh J, Yang J, et al. Topographic diversity of fungal and bacterial communities in human skin[J]. Nature, 2013, 498(7454): 367-370. doi: 10.1038/nature12171

    [11]

    Tanigawa T, Watanabe T, Higashimori A, et al. Rebamipide ameliorates indomethacin-induced small intestinal damage and proton pump inhibitor-induced exacerbation of this damage by modulation of small intestinal microbiota[J]. PLoS One, 2021, 16(1): e0245995. doi: 10.1371/journal.pone.0245995

    [12]

    Chao G, Zhang S. Therapeutic effects of muscovite to non-steroidal anti-inflammatory drugs-induced small intestinal disease[J]. Int J Pharm, 2012, 436(1-2): 154-160. doi: 10.1016/j.ijpharm.2012.05.063

    [13]

    Nastos C, Kalimeris K, Papoutsidakis N, et al. Antioxidant treatment attenuates intestinal mucosal damage and gut barrier dysfunction after major hepatectomy. Study in a porcine model[J]. J Gastrointest Surg, 2011, 15(5): 809-817. doi: 10.1007/s11605-011-1475-0

    [14]

    吕宾. 非甾体抗炎药相关胃肠黏膜损害及防治[J]. 中华消化杂志, 2011, 31(3): 208-310. doi: 10.3760/cma.j.issn.0254-1432.2011.03.021

    [15]

    Goldstein JL, Eisen GM, Lewis B, et al. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo[J]. Clin Gastroenterol Hepatol, 2005, 3(2): 133-141. doi: 10.1016/S1542-3565(04)00619-6

    [16]

    Maiden L, Thjodleifsson B, Theodors A, et al. A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy[J]. Gastroenterology, 2005, 128(5): 1172-1178. doi: 10.1053/j.gastro.2005.03.020

    [17]

    Chen YL, Li ZS, Zhang HQ, et al. Clinical Effects of Biling Weitong Granules in Combination with Quadruple Therapy on Refractory Helicobacter pylori Infection[J]. Altern Ther Health Med, 2023, 29(5): 274-277.

    [18]

    Lam S, Zuo T, Ho M, et al. Review article: fungal alterations in inflammatory bowel diseases[J]. Aliment Pharmacol Ther, 2019, 50(11-12): 1159-1171. doi: 10.1111/apt.15523

    [19]

    Shuai M, Fu Y, Zhong HL, et al. Mapping the human gut mycobiome in middle-aged and elderly adults: multiomics insights and implications for host metabolic health[J]Gut, 2022, 71(9): 1812-1820. doi: 10.1136/gutjnl-2021-326298

    [20]

    Limon JJ, Tang J, Li D, et al. Malassezia Is Associated with Crohn's Disease and Exacerbates Colitis in Mouse Models[J]. Cell Host Microbe, 2019, 25(3): 377-388.e6. doi: 10.1016/j.chom.2019.01.007

    [21]

    Wolf AJ, Limon JJ, Nguyen C, et al. Malassezia spp. induce inflammatory cytokines and activate NLRP3 inflammasomes in phagocytes[J]. J Leukoc Biol, 2021, 109(1): 161-172. doi: 10.1002/JLB.2MA0820-259R

    [22]

    Mueller KD, Zhang H, Serrano CR, et al. Gastrointestinal microbiota alteration induced by Mucor circinelloides in a murine model[J]. J Microbiol, 2019, 57(6): 509-520. doi: 10.1007/s12275-019-8682-x

    [23]

    Speakman EA, Dambuza IM, Salazar F, et al. T Cell Antifungal Immunity and the Role of C-Type Lectin Receptors[J]. Trends Immunol, 2020, 41(1): 61-76. doi: 10.1016/j.it.2019.11.007

  • 加载中

(3)

计量
  • 文章访问数:  325
  • PDF下载数:  93
  • 施引文献:  0
出版历程
收稿日期:  2023-10-23
刊出日期:  2023-12-15

目录